全文获取类型
收费全文 | 7841篇 |
免费 | 435篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 86篇 |
儿科学 | 163篇 |
妇产科学 | 150篇 |
基础医学 | 962篇 |
口腔科学 | 149篇 |
临床医学 | 696篇 |
内科学 | 1847篇 |
皮肤病学 | 314篇 |
神经病学 | 692篇 |
特种医学 | 186篇 |
外科学 | 1066篇 |
综合类 | 34篇 |
一般理论 | 5篇 |
预防医学 | 736篇 |
眼科学 | 196篇 |
药学 | 395篇 |
中国医学 | 13篇 |
肿瘤学 | 624篇 |
出版年
2023年 | 45篇 |
2022年 | 110篇 |
2021年 | 222篇 |
2020年 | 123篇 |
2019年 | 206篇 |
2018年 | 241篇 |
2017年 | 146篇 |
2016年 | 146篇 |
2015年 | 208篇 |
2014年 | 278篇 |
2013年 | 430篇 |
2012年 | 598篇 |
2011年 | 588篇 |
2010年 | 375篇 |
2009年 | 304篇 |
2008年 | 545篇 |
2007年 | 543篇 |
2006年 | 513篇 |
2005年 | 465篇 |
2004年 | 415篇 |
2003年 | 384篇 |
2002年 | 359篇 |
2001年 | 61篇 |
2000年 | 58篇 |
1999年 | 70篇 |
1998年 | 64篇 |
1997年 | 64篇 |
1996年 | 54篇 |
1995年 | 51篇 |
1994年 | 46篇 |
1993年 | 57篇 |
1992年 | 46篇 |
1991年 | 59篇 |
1990年 | 37篇 |
1989年 | 23篇 |
1988年 | 29篇 |
1987年 | 17篇 |
1986年 | 29篇 |
1985年 | 22篇 |
1984年 | 27篇 |
1983年 | 27篇 |
1982年 | 27篇 |
1981年 | 25篇 |
1980年 | 20篇 |
1979年 | 10篇 |
1978年 | 19篇 |
1977年 | 15篇 |
1976年 | 11篇 |
1975年 | 14篇 |
1973年 | 14篇 |
排序方式: 共有8314条查询结果,搜索用时 15 毫秒
101.
Molecular discrimination of atypical bovine spongiform encephalopathy strains from a geographical region spanning a wide area in Europe 总被引:1,自引:0,他引:1 下载免费PDF全文
Jacobs JG Langeveld JP Biacabe AG Acutis PL Polak MP Gavier-Widen D Buschmann A Caramelli M Casalone C Mazza M Groschup M Erkens JH Davidse A van Zijderveld FG Baron T 《Journal of clinical microbiology》2007,45(6):1821-1829
Transmissible spongiform encephalopathy strains can be differentiated by their behavior in bioassays and by molecular analyses of the disease-associated prion protein (PrP) in a posttranslationally transformed conformation (PrPSc). Until recently, isolates from cases of bovine spongiform encephalopathy (BSE) appeared to be very homogeneous. However, a limited number of atypical BSE isolates have recently been identified upon analyses of the disease-associated proteinase K (PK) resistance-associated moiety of PrPSc (PrPres), suggesting the existence of at least two additional BSE PrPres variants. These are defined here as the H type and the L type, according to the higher and lower positions of the nonglycosylated PrPres band in Western blots, respectively, compared to the position of the band in classical BSE (C-type) isolates. These molecular PrPres variants, which originated from six different European countries, were investigated together. In addition to the migration properties and glycosylation profiles (glycoprofiles), the H- and L-type isolates exhibited enhanced PK sensitivities at pH 8 compared to those of the C-type isolates. Moreover, H-type BSE isolates exhibited differences in the binding of antibodies specific for N- and more C-terminal PrP regions and principally contained two aglycosylated PrPres moieties which can both be glycosylated and which is thus indicative of the existence of two PrPres populations or intermediate cleavage sites. These properties appear to be consistent within each BSE type and independent of the geographical origin, suggesting the existence of different BSE strains in cattle. The choice of three antibodies and the application of two pHs during the digestion of brain homogenates provide practical and diverse tools for the discriminative detection of these three molecular BSE types and might assist with the recognition of other variants. 相似文献
102.
Paul Zemaitis Kiang Liu David R. Jacobs Jr. Mary Cushman Ramon Durazo-Arvizu David Shoham Walter Palmas Richard Cooper Holly Kramer 《Clinical journal of the American Society of Nephrology》2014,9(11):1922-1929
Background and objectives
Cumulative exposure to elevated systolic BP (cumSBP) may affect progression of urine albumin excretion in the absence of diabetes. The objective of this study was to examine the association between cumSBP exposure and progression of spot urine albumin-to-creatinine ratio (UACR) in a multi-ethnic cohort of adults without diabetes.Design, setting, participants, & measurements
The analysis included 3789 participants without severely increased urine albumin excretion or diabetes in the Multi-Ethnic Study of Atherosclerosis, a cohort of 6814 adults aged 45–84 years. UACR was measured at baseline and approximately 1.6, 3.1, and 9.4 years after the baseline examination. cumSBP was calculated as the summed average systolic BP (SBP; mmHg) between two consecutive examinations multiplied by the time between the two examinations (mmHg×year) and categorized as ≤1128 (SBP<120 mmHg), 1129–1222 (SBP≥120–129 mmHg), 1223–1316 (SBP≥130–130 mmHg), and >1316 (SBP≥140 mmHg). Baseline UACR was categorized as normal, mildly increased, or moderately increased, and definite progression of UACR was defined as a persistently higher UACR category at subsequent examinations. No UACR progression was defined as remaining in the same UACR category across all examinations or regressing.Results
In fully adjusted models, compared with cumSBP≤1128 mmHg, cumSBP 1223–1316 and >1316 mmHg was associated with a 85% and 130% significantly higher odds of definite UACR progression (95% confidence interval, 24% to 178% and 56% to 243%, respectively) versus no UACR progression. Every 100-mmHg higher level of cumSBP was associated with a 1.23-fold higher odds of definite UACR progression (95% confidence interval, 1.13 to 1.34) versus no UACR progression.Conclusion
Exposure to higher cumSBP was associated with increased UACR progression among adults without diabetes. 相似文献103.
104.
Carla Ferrándiz‐Pulido Javier Hernández‐Losa Emili Masferrer Ana Vivancos Rosa Somoza Roso Marés Claudia Valverde Carlos Salvador Jose Placer Juan Morote Ramon M. Pujol Santiago Ramon y Cajal Vicente García‐Patos 《Genes, chromosomes & cancer》2015,54(10):629-637
There is a lack of studies on somatic gene mutations and cell signaling driving penile carcinogenesis. Our objective was to analyze somatic mutations in genes downstream of EGFR in penile squamous cell carcinomas, especially the mTOR and RAS/MAPK pathways. We retrospectively analyzed somatic mutations in 10 in situ and 65 invasive penile squamous cell carcinomas by using Sequenom's Mass Spectrometry iPlex Technology and Oncocarta v1.0 Panel. The DNA was extracted from FFPE blocks and we identified somatic missense mutations in three in situ tumors and in 19 invasive tumors, mostly in PIK3CA, KRAS, HRAS, NRAS, and PDGFA genes. Somatic mutations in the PIK3CA gene or RAS family genes were neither associated with tumor grade, stage or outcome, and were equally often identified in hrHPV positive and in hrHPV negative tumors that showed no p53 expression. Mutations in PIK3CA, KRAS, and HRAS are frequent in penile squamous cell carcinoma and likely play a role in the development of p53‐negative tumors. Although the presence of these mutations does not seem to correlate with tumoral behavior or outcome, they could be biomarkers of treatment failure with anti‐EGFR mAb in patients with penile squamous cell carcinoma. © 2015 Wiley Periodicals, Inc. 相似文献
105.
STUDY OBJECTIVES: To assess whether the measurement of breathing reduction during obstructive sleep events depends on using the flow or the volume signals recorded with a pneumotachograph. DESIGN: Prospective observational study. SETTING: Sleep laboratory in a University Hospital. PATIENTS OR PARTICIPANTS: Data from 10 male patients with sleep apnea (54 +/- 11 years, apnea-hypopnea index: 43 +/- 21 events/hour, body mass index: 30 +/- 2 kg/m2). INTERVENTIONS: Slow modification of continuous positive airway pressure was performed during full-polysomnography continuous positive airway pressure titration. MEASUREMENTS AND RESULTS: Air flow was measured by a pneumotachograph, and volume was computed by numerical integration. Obstructive events of different magnitude were selected. In 500 breathing cycles analyzed, the reduction in tidal volume was greater than the reduction in the flow amplitude: mean difference of 0.091 (i.e., 9.1% amplitude) and limits of agreement of 0.095 and -0.277 (i.e., 9.5% and -27.7% amplitude). In 14% of the cycles, the reduction in flow was < 50%, whereas the reduction in volume was > 50%, resulting in discordant event classification. CONCLUSIONS: The quantification of breathing reduction depends on whether the flow or the volume signal is used to assess breathing during sleep. 相似文献
106.
ND5 is a hot-spot for multiple atypical mitochondrial DNA deletions in mitochondrial neurogastrointestinal encephalomyopathy 总被引:5,自引:0,他引:5
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is an autosomal recessive multisystem disorder associated with depletion, multiple deletions and site-specific point mutations of mitochondrial DNA (mtDNA). MNGIE is caused by loss-of-function mutations in the gene encoding thymidine phosphorylase (TP; endothelial cell growth factor 1). Deficiency of TP leads to dramatically elevated levels of circulating thymidine and deoxyuridine. The alterations of pyrimidine nucleoside metabolism are hypothesized to cause imbalances of mitochondrial nucleotide pools that, in turn, may cause somatic alterations of mtDNA. We have now identified five major forms of mtDNA deletions in the skeletal muscle of MNGIE patients. While direct repeats and imperfectly homologous sequences appear to mediate the formation of mtDNA deletions, the nicotinamide adenine dinucleotide dehydrogenase 5 gene is a hot-spot for these rearrangements. A novel aspect of the mtDNA deletions in MNGIE is the presence of microdeletions at the imperfectly homologous breakpoints. 相似文献
107.
Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children 总被引:2,自引:0,他引:2 下载免费PDF全文
Canh DG Lin FY Thiem VD Trach DD Trong ND Mao ND Hunt S Schneerson R Robbins JB Chu C Shiloach J Bryla DA Bonnet MC Schulz D Szu SC 《Infection and immunity》2004,72(11):6586-6588
In a double-blind, randomized, and placebo-controlled previous trial, the efficacy of Vi-rEPA for typhoid fever in 2- to 5-year-olds was 89.0% for 46 months. Vi-rEPA contained 25 microg of Vi and induced a greater-than-eightfold rise in immunoglobulin G (IgG) anti-Vi in all of the vaccinees tested. In this investigation, we conducted a dosage-immunogenicity study of 5, 12.5, and 25 microg of Vi-rEPA in this age group. Two doses of Vi-rEPA were injected 6 weeks apart. Blood samples were taken before and at 10 weeks (4 weeks after the second injection) and 1 year later. All postimmunization geometric mean (GM) levels were higher than the preimmune levels (P < 0.0001). At 10 weeks, the GM IgG anti-Vi level elicited by 25 microg (102 EU/ml) was higher than those elicited by 12.5 microg (74.7 EU/ml) and 5 microg (43 EU/ml) (P < 0.004): all of the children had > or = 3.52 EU/ml (estimated minimum protective level). One year later, the levels declined about sevenfold (13.3 and 11.3 versus 6.43 EU/ml, P < 0.0001) but remained significantly higher than the preimmune levels (P < 0.0001), and >96% of the children had a greater-than-eightfold rise. This study also confirmed the safety and consistent immunogenicity of the four lots of Vi-rEPA used in this and previous trials. 相似文献
108.
Carolina Carrillo Josep Maria Suñé Pilar Pérez-Lozano Encarna García-Montoya Rocío Sarrate Anna Fàbregas Montserrat Miñarro Josep Ramon Ticó 《Biomedicine & Pharmacotherapy》2014
Chitosan has been studied for use in particle delivery systems for therapeutic purposes, since one of its most important applications is as a non-viral vector in gene therapy. Due to its positive charge, it is capable of forming DNA complexes (polyplexes) obtained through several methods and with the property of protecting nucleic acids. Two methods for obtaining the nanoparticles of chitosan-nucleic acids are reported in this study: simple complexation (of depolymerized chitosan or of different chitosan salts with plasmid) and ionic gelation (by adsorption of plasmid in the nanoparticles or by encapsulation of plasmid into nanoparticles). The determination of the loading efficiency of chitosan nanoparticles with the plasmid is carried out by electrophoretic mobility of the samples on agarose gel. Furthermore, the nanoparticles have been characterized according to their morphology, size and surface charge using AFM, TEM, laser diffraction and dynamic light scattering techniques. The polyplexes obtained have been found to be spherical and nanometric in size (between 100–230 nm) with a zeta potential between 37 and 48 mV. Positive results have been obtained by agarose gel electrophoresis for all studied cases: a concentration of between 20 and 30 μg/mL of chitosan salts is required while for the remaining chitosan samples studied, 100% loading efficiency does not occur until a concentration equal to 100 μg/mL (regardless of previous depolymerisation and the method performed). Chitosan–plasmid nanocapsules have been obtained at the polymer concentrations worked with (between 0.025 and 0.2%). 相似文献
109.
The main purpose of the article is to present the possibilities of producing composite reinforcement with the use of a computer embroidery machine. The study below presents the results of strength tests of composites containing technical embroidery, woven fabric, and UD fabric as the reinforcement. Each of the samples was made of the same material—flax roving. The samples differed from each other in the arrangement of layers in the reinforcement. The composites were made using the infusion method with epoxy resin. The embroidery was made on a ZSK embroidery machine, type JCZA 0109-550. A total of 12 types of composites were produced and tested. The test material was subjected to strength tests—tensile strength, tensile elongation, and shear strength, on the INSTRON machine. As the research showed, the use of technical embroidery as a composite reinforcement increases its tensile strength. Furthermore, the use of embroidery is a vertical reinforcement of the composite and prevents the formation of interlayer cracks. The technology of technical embroidery allows for optimizing the mechanical values of the composite reinforcement. 相似文献
110.
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders 下载免费PDF全文
Pérez-Simón JA Kottaridis PD Martino R Craddock C Caballero D Chopra R García-Conde J Milligan DW Schey S Urbano-Ispizua A Parker A Leon A Yong K Sureda A Hunter A Sierra J Goldstone AH Linch DC San Miguel JF Mackinnon S;Spanish United Kingdom Collaborative Groups for Nonmyeloablative Transplantation 《Blood》2002,100(9):3121-3127
Although nonmyeloablative conditioning regimen transplantations (NMTs) induce engraftment of allogeneic stem cells with a low spectrum of toxicity, graft-versus-host disease (GVHD) remains a significant cause of morbidity and mortality. In vivo T-cell depletion, using alemtuzumab, has been shown to reduce the incidence of GVHD. However, this type of maneuver, although reducing GVHD, may have an adverse impact on disease response, because NMTs exhibit their antitumor activity by relying on a graft-versus-malignancy effect. To explore the efficacy of alemtuzumab compared with methotrexate (MTX) for GVHD prophylaxis, we have compared the results in 129 recipients of a sibling NMT enrolled in 2 prospective studies for chronic lymphoproliferative disorders. Both NMTs were based on the same combination of fludarabine and melphalan, but the United Kingdom regimen (group A) used cyclosporin A plus alemtuzumab, whereas the Spanish regimen (group B) used cyclosporin A plus MTX for GVHD prophylaxis. Patients receiving alemtuzumab had a higher incidence of cytomegalovirus (CMV) reactivation (85% versus 24%, P <.001) and a significantly lower incidence of acute GVHD (21.7% versus 45.1%, P =.006) and chronic GVHD (5% versus 66.7%, P <.001). Twenty-one percent of patients in group A and 67.5% in group B had complete or partial responses 3 months after transplantation (P <.001). Eighteen patients in group A received donor lymphocyte infusions (DLIs) to achieve disease control. At last follow-up there was no difference in disease status between the groups with 71% versus 67.5% (P =.43) of patients showing complete or partial responses in groups A and B, respectively. No significant differences were observed in event-free or overall survival between the 2 groups. In conclusion, alemtuzumab significantly reduced GVHD but its use was associated with a higher incidence of CMV reactivation. Patients receiving alemtuzumab often required DLIs to achieve similar tumor control but the incidence of GVHD was not significantly increased after DLI. 相似文献